- Home
- KALV vs DFP Comparison
KALV vs DFP Comparison
Compare KALV & DFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- DFP
- Stock Information
- Founded
- KALV N/A
- DFP 2013
- Country
- KALV United States
- DFP United States
- Employees
- KALV N/A
- DFP N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- DFP Investment Managers
- Sector
- KALV Health Care
- DFP Finance
- Exchange
- KALV Nasdaq
- DFP Nasdaq
- Market Cap
- KALV 362.2M
- DFP 418.8M
- IPO Year
- KALV N/A
- DFP N/A
- Fundamental
- Price
- KALV $10.03
- DFP $20.48
- Analyst Decision
- KALV Strong Buy
- DFP
- Analyst Count
- KALV 8
- DFP 0
- Target Price
- KALV $25.67
- DFP N/A
- AVG Volume (30 Days)
- KALV 321.8K
- DFP 56.2K
- Earning Date
- KALV 03-10-2025
- DFP 01-01-0001
- Dividend Yield
- KALV N/A
- DFP 6.73%
- EPS Growth
- KALV N/A
- DFP N/A
- EPS
- KALV N/A
- DFP N/A
- Revenue
- KALV N/A
- DFP N/A
- Revenue This Year
- KALV N/A
- DFP N/A
- Revenue Next Year
- KALV N/A
- DFP N/A
- P/E Ratio
- KALV N/A
- DFP N/A
- Revenue Growth
- KALV N/A
- DFP N/A
- 52 Week Low
- KALV $7.30
- DFP $15.45
- 52 Week High
- KALV $15.50
- DFP $19.31
- Technical
- Relative Strength Index (RSI)
- KALV 59.09
- DFP 49.69
- Support Level
- KALV $8.99
- DFP $20.57
- Resistance Level
- KALV $11.00
- DFP $20.80
- Average True Range (ATR)
- KALV 0.57
- DFP 0.19
- MACD
- KALV 0.11
- DFP 0.00
- Stochastic Oscillator
- KALV 57.08
- DFP 43.97
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About DFP Flaherty & Crumrine Dynamic Preferred and Income Fund Inc.
Flaherty & Crumrine Pref&Inc Allocation is a diversified, closed-end management investment company. Its investment objective is to seek total return, with an emphasis on high current income.